Pulmonary Fibrosis Clinical Trials in Melbourne, Victoria
6 recruitingMelbourne, Victoria, Australia
Showing 1–6 of 6 trials
Recruiting
Phase 3
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
Progressive Pulmonary FibrosisIdiopathic Pulmonary Fibrosis
Boehringer Ingelheim1,700 enrolled371 locationsNCT06238622
Recruiting
Phase 3
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
Interstitial Lung DiseasesFamilial Pulmonary FibrosisInterstitial Lung Abnormalities
Boehringer Ingelheim80 enrolled56 locationsNCT07201922
Recruiting
Phase 2
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
Progressive Pulmonary FibrosisInterstitial Lung DiseasePulmonary Fibrosis+4 more
Avalyn Pharma Inc.375 enrolled152 locationsNCT06329401
Recruiting
PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
Progressive Pulmonary FibrosisInterstitial Lung Disease
University of Massachusetts, Worcester500 enrolled13 locationsNCT06855329
Recruiting
Not Applicable
A Randomised Clinical Trial of a Digital Self-management Package for People With Interstitial Lung Disease
Lung Diseases, InterstitialPulmonary Fibrosis
University of Sydney400 enrolled4 locationsNCT06122233
Recruiting
Phase 1
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of RSN0402 in Healthy Volunteers
Idiopathic Pulmonary FibrosisLung; Disease, Interstitial, With Fibrosis
Shenzhen Resproly Biopharmaceutical Co., Ltd72 enrolled3 locationsNCT06482190